国际英语新闻:WHO investigates reports of AstraZeneca COVID-19 vaccine blood clots

GENEVA, March 12 (Xinhua) -- Head of the World Health Organization (WHO) said on Friday that the Geneva-based UN health agency "systematically reviews safety signals, and is carefully assessing the current reports on the AstraZeneca vaccine."

The COVID-19 vaccine developed by AstraZeneca and the University of Oxford has been suspended in a number of countries across Europe and Asia, following reports of blood clots in some vaccinated people.

"WHO is aware that some countries have suspended the use of AstraZeneca vaccines, based on reports of blood clots in some people who received doses of the vaccine from two batches. This measure was taken as a precaution while a full investigation is finalized," said WHO Director-General Dr. Tedros Adhanom Ghebreyesus at a press briefing on Friday.

A number of countries like Denmark, Norway, Iceland, Romania and Thailand have suspended the rollout of the AstraZeneca/Oxford vaccine after it was linked to blood clots in recipients, while Austria and France have decided to continue using it.

"It is important to note that the European Medicines Agency has said there is no indication of a link between the vaccine and blood clots, and that the vaccine can continue to be used while its investigation is ongoing," Tedros said.

The European Commission said on Thursday that the AstraZeneca vaccine is still safe to use, adding that the European Medicines Agency (EMA) had adopted a preliminary review on the case in Austria "where they said there is no specific indication that the vaccination led to these conditions."

"As soon as WHO has gained a full understanding of these events, the findings and any changes to our current recommendations will be communicated immediately to the public," Tedros said.

The WHO chief also said that more than 335 million COVID-19 vaccine doses have been administered globally so far, and no deaths have been found to have been caused by them.

"But at least 2.6 million people have been killed by the virus. And more will continue to die the longer it takes to distribute vaccines as rapidly and as equitably as possible," he said.

As countries roll out COVID-19 vaccines, the WHO is continuing to keep a close eye on their safety, Tedros added.

Also on Friday, WHO gave emergency use listing to Johnson & Johnson's COVID-19 vaccine, making it the fourth vaccine to receive WHO's approval. Emergency use listing is the green light for a vaccine to be procured and rolled out by COVAX, he said, referencing the global WHO-led initiative to ensure vaccine equity.

As the world is struggling to contain the pandemic, vaccination is underway in an increasing number of countries with the already-authorized coronavirus vaccines.

Meanwhile, 263 candidate vaccines are still being developed worldwide -- 81 of them in clinical trials -- in countries including Germany, China, Russia, Britain, and the United States, according to information released by the World Health Organization on March 12.